Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apraclonidine vs timolol to prevent intraocular pressure rise after YAG laser capsulotomy
IRCT201109267218N2Phase 2Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in posterior capsule opacification (PCO) and ocular hypertension comparing Apraclonidine with Timolol (2 arms). Primary endpoint: Change in intraocular pressure after YAG capsulotomy. Started Sep 2009; status: completed.
02
Drugs
apraclonidinetimolol
03
Conditions
posterior capsule opacification (PCO)ocular hypertension
Beyond the preview
Go deeper on IRCT201109267218N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201109267218N2.